https://www.zacks.com/stock/news/2208783/how-wix-com-wix-stock-stands-out-in-a-strong-industry?cid=CS-ZC-FT-tale_of_the_tape|industry_rank_and_rising_estimates-2208783
Jan 11, 2024 - Wix.com (WIX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
zc:-229183704023200973
0
https://www.fool.com/investing/2024/01/11/are-you-missing-out-on-this-passive-income-stocks/?source=iedfolrf0000001
Jan 11, 2024 - It isn't every day that a company increases its dividend at a double-digit rate.
0
fool:4565974094427364696
0
https://seekingalpha.com/article/4662278-uranium-miners-breaking-out-technical-analysis?source=feed_all_articles
Jan 10, 2024 - Uranium miners broke out higher after a 3-month consolidation, potentially signaling a return of upside momentum. Learn more about the URA ETF here.
0
sa:5730167347961320009
0
https://www.wired.com/story/sec-x-account-hack-investigation/
Jan 10, 2024 - The US Securities and Exchange Commission is under pressure to explain itself after its X account was compromised, leading to wild swings in the bitcoin market.
0
wr:-2056275045361727374
0
https://www.zacks.com/stock/news/2208320/analysts-estimate-the-charles-schwab-corporation-schw-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2208320
Jan 10, 2024 - The Charles Schwab Corporation (SCHW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zc:-1408684131261557915
0
https://www.zacks.com/stock/news/2208217/how-neurocrine-nbix-stock-stands-out-in-a-strong-industry?cid=CS-ZC-FT-tale_of_the_tape|industry_rank_and_rising_estimates-2208217
Jan 10, 2024 - Neurocrine (NBIX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
zc:-1523331577321922172
0
https://www.zacks.com/stock/news/2208132/how-fusion-pharmaceuticals-fusn-stock-stands-out-in-a-strong-industry?cid=CS-ZC-FT-tale_of_the_tape|industry_rank_and_rising_estimates-2208132
Jan 10, 2024 - Fusion Pharmaceuticals (FUSN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
zc:-7608702261358761988
0
https://www.zacks.com/stock/news/2207850/core-main-cnm-recently-broke-out-above-the-20-day-moving-average?cid=CS-ZC-FT-tale_of_the_tape|20_day_moving_average_(yseop)-2207850
Jan 09, 2024 - Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
zc:-4001697061649567014
0
https://www.zacks.com/stock/news/2207852/james-hardie-jhx-recently-broke-out-above-the-20-day-moving-average?cid=CS-ZC-FT-tale_of_the_tape|20_day_moving_average_(yseop)-2207852
Jan 09, 2024 - Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
zc:2187833731654350484
0
https://www.zacks.com/stock/news/2207855/crowdstrike-holdings-crwd-recently-broke-out-above-the-20-day-moving-average?cid=CS-ZC-FT-tale_of_the_tape|20_day_moving_average_(yseop)-2207855
Jan 09, 2024 - When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
zc:-7209811686067099748
0